Happy new year

Kia ora koutou and happy new year from the team at Rua Bioscience.

The final quarter of 2024 proved to be an exciting and rewarding time for us, filled with milestones, growth, and community impact. Here’s a breakdown of the latest updates, our financial performance highlights, and a glimpse at what’s ahead in 2025.

Final quarter 2024

New product in Germany

Our recent product launch has been very well received by both consumers and industry experts alike, reaffirming our position as an important player in this key market sector. This positive response highlights our commitment to quality and innovation.

New products in the UK

December marked our entry into the UK market with the launch of three medicinal cannabis products in partnership with Target Healthcare. The UK is now officially the fourth key market alongside Germany, New Zealand, and Australia, opening new growth opportunities for revenue streams.

New product in Aotearoa New Zealand

An additional dried flower product is now available for prescribers and patients to consider in our very important home market, providing more options for those seeking alternative therapies. Initial feedback from both medical professionals and patients has been overwhelmingly positive, indicating a strong interest and potential benefits.

Scholarships

One of the most rewarding aspects of our work is enabling rangatahi to advance in their educational journeys. In December, we collaborated with local kura (schools) to identify 14 scholars who are preparing to further their studies. We are pleased to offer a small contribution to support their academic pursuits. This initiative would not be possible without the invaluable support and contributions from Trust Tairawhiti and Blackbee Contractors.

Looking ahead

The next year holds exciting prospects for Rua Bioscience:

  • Market Growth – We will continue leveraging our strong distribution channels to expand our product lines and grow within our four key markets.

  • Innovation – Bring our unique genetics to more patients while maintaining and enhancing product quality.

  • Community Impact – Continue supporting communities and fostering social change alongside our business growth.

We are committed to driving sustainable growth while delivering value to both our shareholders and the communities we connect with.

Stay up to date

Stay up to date with all the latest news and updates at www.ruabio.com/news where you can read about our product launches, market insights, and investor news.

Keep an eye out for announcements around the end of February for our half year financial reports at www.ruabio.com/investorcentre

Nga mihi nui

Previous
Previous

Psilocybin clinical trial update

Next
Next

Launch of Products in the UK